Cargando…
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1
INTRODUCTION: We have previously reported that induction of epidermal growth factor receptor and ErbB2 in response to antihormonal agents may provide an early mechanism to allow breast cancer cells to evade the growth-inhibitory action of such therapies and ultimately drive resistant cell growth. Mo...
Autores principales: | Hutcheson, Iain R, Goddard, Lindy, Barrow, Denise, McClelland, Richard A, Francies, Hayley E, Knowlden, Janice M, Nicholson, Robert I, Gee, Julia MW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219190/ https://www.ncbi.nlm.nih.gov/pubmed/21396094 http://dx.doi.org/10.1186/bcr2848 |
Ejemplares similares
-
Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins
por: Hutcheson, IR, et al.
Publicado: (2010) -
Recruitment of insulin receptor substrate-1 by erbB3 impacts on IGF-IR signalling in oestrogen receptor-positive breast cancer cells
por: Knowlden, JM, et al.
Publicado: (2010) -
erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines
por: Knowlden, Janice M, et al.
Publicado: (2011) -
Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer
por: Mitsui, Keigo, et al.
Publicado: (2014) -
The Role of ErbB Receptors in Infection
por: Ho, Jemima, et al.
Publicado: (2017)